CVE:NUNeutriSci International Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NeutriSci International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.06 -0.01 (-14.29 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.06Now: C$0.06▼C$0.0750-Day RangeC$0.03MA: C$0.05▼C$0.0752-Week RangeC$0.02Now: C$0.06▼C$0.09Volume550,000 shsAverage Volume283,784 shsMarket CapitalizationC$8.65 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesSocial Media NeutriSci International Inc. develops and markets nutraceutical products in Canada and internationally. It offers Neuenergy, a chewable tablet designed to deliver enhanced focus and mental clarity; nu.thc and nu.cbd sugar-free chewable cannabinoid tablets that offer a metered dose of THC/CBD; and BluScience line of products to support optimal health. The company markets its products through retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for NeutriSci International. Previous Next 2.5 Community Rank Outperform VotesNeutriSci International has received 19 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNeutriSci International has received 19 “underperform” votes. (Add your “underperform” vote.)Community SentimentNeutriSci International has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NeutriSci International and other stocks. Vote “Outperform” if you believe NU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NU will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNeutriSci International does not currently pay a dividend.Dividend GrowthNeutriSci International does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NeutriSci International insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NeutriSci International is -4.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeutriSci International is -4.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:NU Previous Symbol CUSIPN/A CIKN/A Webwww.neutrisci.com Phone403-264-6320Debt Debt-to-Equity RatioN/A Current Ratio0.73 Quick Ratio0.03Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$96,538.00 Price / Sales89.60 Cash FlowC$0.01 per share Price / Cash Flow7.00 Book ValueC$0.00 per share Price / Book-60.00Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares144,159,008Market CapC$8.65 million Next Earnings Date6/4/2020 (Estimated) OptionableNot Optionable TSXV:NU Rates by TradingView Receive NU News and Ratings via Email Sign-up to receive the latest news and ratings for NU and its competitors with MarketBeat's FREE daily newsletter. NeutriSci International (CVE:NU) Frequently Asked Questions How has NeutriSci International's stock been impacted by COVID-19 (Coronavirus)? NeutriSci International's stock was trading at C$0.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NU shares have increased by 50.0% and is now trading at C$0.06. View which stocks have been most impacted by Coronavirus. When is NeutriSci International's next earnings date? NeutriSci International is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for NeutriSci International. Has NeutriSci International been receiving favorable news coverage? Headlines about NU stock have trended somewhat positive on Sunday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. NeutriSci International earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutNeutriSci International. Who are some of NeutriSci International's key competitors? Some companies that are related to NeutriSci International include Cipher Pharmaceuticals (CPH), Indiva (NDVA), Harvest One Cannabis (HVT), MGC Pharmaceuticals (MXC), Eve & Co Inc (EVE), SugarBud Craft Growers (SUGR), Evgen Pharma (EVG), Lattice Biologics (LBL), Cannpal Animal Therapeutics (CP1), Aequus Pharmaceuticals (AQS), 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG) and Applied Biosciences (APPB). View all competitors. What other stocks do shareholders of NeutriSci International own? Based on aggregate information from My MarketBeat watchlists, some companies that other NeutriSci International investors own include Aurora Cannabis (ACB), Emcor Group (EME), Incyte (INCY), Northwest Pipe (NWPX), UnitedHealth Group (UNH), Watsco (WSO), Zimmer Biomet (ZBH), 3i Infrastructure (3IN), Axos Financial (AX) and Actinium Pharmaceuticals (ATNM). Who are NeutriSci International's key executives? NeutriSci International's management team includes the following people: Mr. Glen Rehman, CEO, Pres & DirectorMr. John Robert Chisholm, Chief Financial Officer (Age 57)Mr. Thierry Sorhaitz, VP of Sales & Marketing What is NeutriSci International's stock symbol? NeutriSci International trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NU." How do I buy shares of NeutriSci International? Shares of NU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is NeutriSci International's stock price today? One share of NU stock can currently be purchased for approximately C$0.06. How big of a company is NeutriSci International? NeutriSci International has a market capitalization of C$8.65 million and generates C$96,538.00 in revenue each year. What is NeutriSci International's official website? The official website for NeutriSci International is www.neutrisci.com. How can I contact NeutriSci International? The company can be reached via phone at 403-264-6320. This page was last updated on 5/31/2020 by MarketBeat.com Staff
